Results 271 to 280 of about 2,693,459 (310)
Some of the next articles are maybe not open access.
International Journal of Cardiology, 2006
Heart failure is reaching epidemic proportions as a major cause of morbidity and mortality in developed countries. It accounts for at least 5% of hospital admissions in the UK. The overall annual incidence of heart failure is 0.08% rising from 0.02% at age 45–55years to 1.2% at age 86years or over [1].
Thomas, Martin D. +2 more
openaire +3 more sources
Heart failure is reaching epidemic proportions as a major cause of morbidity and mortality in developed countries. It accounts for at least 5% of hospital admissions in the UK. The overall annual incidence of heart failure is 0.08% rising from 0.02% at age 45–55years to 1.2% at age 86years or over [1].
Thomas, Martin D. +2 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1965
Patients with cardiac decompensation who fail to respond satisfactorily to routine therapeutic measures are generally categorized as having refractory heart failure. Among the multiple pathophysiologic mechanisms involved are disturbed myocardial function, diminished cardiac output, decreased renal hemodynamic functions, and aldosteronism.1 From a ...
R H, SELLER +3 more
openaire +2 more sources
Patients with cardiac decompensation who fail to respond satisfactorily to routine therapeutic measures are generally categorized as having refractory heart failure. Among the multiple pathophysiologic mechanisms involved are disturbed myocardial function, diminished cardiac output, decreased renal hemodynamic functions, and aldosteronism.1 From a ...
R H, SELLER +3 more
openaire +2 more sources
Current Cardiology Reports, 1999
Managing patients with heart failure is rooted in appropriate recognition of the syndrome and subsequent tailoring of therapies to individual patients based on the stage of the disease. An individual with asymptomatic left ventricular dysfunction (the earliest stage of heart failure) is treated quite differently than a patient with more advanced heart ...
openaire +2 more sources
Managing patients with heart failure is rooted in appropriate recognition of the syndrome and subsequent tailoring of therapies to individual patients based on the stage of the disease. An individual with asymptomatic left ventricular dysfunction (the earliest stage of heart failure) is treated quite differently than a patient with more advanced heart ...
openaire +2 more sources
Heart Failure: Advanced Refractory Heart Failure.
FP essentials, 2021End-stage heart failure (HF) is associated with an extremely poor prognosis. Progressive and/or persistent HF signs and symptoms in the setting of optimal therapy is the hallmark of more advanced disease. Physicians must be able to recognize patients with features of refractory HF to aid in timely evaluation for advanced therapy options.
openaire +1 more source
VEGFA mRNA for regenerative treatment of heart failure
Nature Reviews Drug Discovery, 2021Anna Collén +2 more
exaly
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
New England Journal of Medicine, 2021Stefan D Anker +2 more
exaly